英文别名ACT-389949; ACT 389949; 2-methyl-5-m-tolyloxazole-4-carboxylic acid (2-(4-(1,1-difluoroethyl)oxazol-2-ylmethyl)-2H-(1,2,3)triazol-4-yl)amide; 2-Methyl-5-m-tolyl-oxazole-4-carboxylic Acid {2-[4-(1,1-difluoro-ethyl)-oxazol-2-ylmethyl]-2H-[1,2,3]triazol-4-yl}-amide; 4-Oxazolecarboxamide, N-(2-((4-(1,1-difluoroethyl)-2-oxazolyl)methyl)-2H-1,2,3-triazol-4-yl)-2-methyl-5-(3-methylphenyl)-; N-(2-((4-(1,1-difluoroethyl)-1,3-oxazol-2-yl)methyl)-2H-1,2,3-triazol-4-yl)-2-methyl-5-(3-methylphenyl)-1,3-oxazole-4-carboxamide; N-(2-{[4-(1,1-difluoroethyl)-1,3-oxazol-2-yl]methyl}-2H-1,2,3-triazol-4-yl)-2-methyl-5-(3-methylphenyl)-1,3-oxazole-4-carboxamide; N-[2-[[4-(1,1-difluoroethyl)-1,3-oxazol-2-yl]methyl]triazol-4-yl]-2-methyl-5-(3-methylphenyl)-1,3-oxazole-4-carboxamide; N-[2-[[4-(1,1-difluoroethyl)oxazol-2-yl]methyl]triazol-4-yl]-2-methyl-5-(m-tolyl)oxazole-4-carboxamide 
